Safeguarding public health – Article from #1 2019

INTRODUCTION In a world with an estimated population of 7.6 billion, 2 billion people lack access to medicines that are imperative to their health and survival. World Health Organization, “Access to Medicine Index 2018 – Methodology Report,” 6. Consequently, 15,000 deaths per day (more than half of the 5.6 million children who died [...]

Safeguarding public health – Article from #1 20192019-05-24T14:10:52+01:00

In Pursuit of Robinson Crusoe – Article from #1 2019

Naming pharmaceuticals is a topic that has been thoroughly investigated and buzzed around, and where the world's expertise agrees on at least one thing. With today's increasingly dense jungle of brands, combined with the famously strict regulations of authorities such as the European Medicines Agency (EMA), the US Food and Drug Administration (FDA) and the [...]

In Pursuit of Robinson Crusoe – Article from #1 20192019-05-24T13:42:45+01:00

The CJEU clarifies – Article from #1 2019

INTRODUCTION Where to draw the line between the protection of new innovations within the pharmaceutical area, on the one hand, and the generic companies’ right to enter the market on the other, has been subject to discussion in patent law for a long time. The innovative pharmaceutical companies’ right to exclusively capitalise on their innovative [...]

The CJEU clarifies – Article from #1 20192019-05-24T13:42:22+01:00
Go to Top